• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种与铁死亡相关的长链非编码RNA特征可预测结肠腺癌的预后。

A Ferroptosis-Related lncRNAs Signature Predicts Prognosis of Colon Adenocarcinoma.

作者信息

Guo Ying, Wang Zehao, Tian Ye, Li Lin, Dong Jing

机构信息

College of Animal Science and Medicine, Shenyang Agricultural University, Shenyang 110866, China.

出版信息

Life (Basel). 2023 Jul 13;13(7):1557. doi: 10.3390/life13071557.

DOI:10.3390/life13071557
PMID:37511932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10381171/
Abstract

(1) Ferroptosis is a type of cellular death caused by lipid-dependent iron peroxide, which plays a major role in cancer. Long noncoding RNAs (lncRNAs) are increasingly recognized as key regulating substances in ferroptosis; (2) RNA sequencing expressions and clinical data of 519 patients with colon adenocarcinoma (COAD) were downloaded from The Cancer Genome Atlas (TCGA) database. The expression levels of lncRNAs related to ferroptosis were screened with Pearson correlation analysis. Differential genes were enriched with Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. LncRNAs related to ferroptosis were determined with univariate Cox regression and multivariate Cox regression analyses, and patients with COAD were classified into high- and low-risk subgroups according to their median risk score. The prognostic value was further examined, and the association between ferroptosis-related lncRNAs (frlncRNAs) and survival in patients with high and low risks of COAD was validated. A TCGA-COAD data set was used for receiver operating characteristic (ROC) analysis and detrended correspondence analysis (DCA) to assess prediction accuracy. Finally, a nomogram was constructed to predict survival probability; (3) We obtained a model consisting of a five-frlncRNAs signature comprising AP003555.1, AP001469.3, ITGB1-DT, AC129492.1, and AC010973.2 for determining the overall survival (OS) of patients with COAD. The survival analysis and ROC curves showed that the model had good robustness and predictive performance on the TCGA training set; (4) We found that a five-frlncRNAs signature may play a potential role in anti-COAD immunity. Risk characteristics based on frlncRNAs can accurately predict the prognosis and immunotherapy response of patients with COAD.

摘要

(1) 铁死亡是一种由脂质依赖性过氧化铁引起的细胞死亡类型,在癌症中起主要作用。长链非编码RNA(lncRNA)越来越被认为是铁死亡中的关键调节物质;(2) 从癌症基因组图谱(TCGA)数据库下载了519例结肠腺癌(COAD)患者的RNA测序表达数据和临床数据。通过Pearson相关分析筛选与铁死亡相关的lncRNA表达水平。差异基因通过基因本体论(GO)和京都基因与基因组百科全书(KEGG)通路进行富集。通过单变量Cox回归和多变量Cox回归分析确定与铁死亡相关的lncRNA,并根据COAD患者的中位风险评分将其分为高风险和低风险亚组。进一步检验预后价值,并验证铁死亡相关lncRNA(frlncRNA)与COAD高风险和低风险患者生存之间的关联。使用TCGA-COAD数据集进行受试者工作特征(ROC)分析和去趋势对应分析(DCA)以评估预测准确性。最后,构建列线图以预测生存概率;(3) 我们获得了一个由五个frlncRNA组成的特征模型,包括AP003555.1、AP001469.3、ITGB1-DT、AC129492.1和AC010973.2,用于确定COAD患者的总生存期(OS)。生存分析和ROC曲线表明该模型在TCGA训练集上具有良好的稳健性和预测性能;(4) 我们发现一个五个frlncRNA的特征可能在抗COAD免疫中发挥潜在作用。基于frlncRNA的风险特征可以准确预测COAD患者的预后和免疫治疗反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01aa/10381171/6f81f7098551/life-13-01557-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01aa/10381171/0b066820b4a9/life-13-01557-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01aa/10381171/2138d20de079/life-13-01557-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01aa/10381171/089434f1d377/life-13-01557-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01aa/10381171/b6ecdae4aacb/life-13-01557-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01aa/10381171/6f81f7098551/life-13-01557-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01aa/10381171/0b066820b4a9/life-13-01557-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01aa/10381171/2138d20de079/life-13-01557-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01aa/10381171/089434f1d377/life-13-01557-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01aa/10381171/b6ecdae4aacb/life-13-01557-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01aa/10381171/6f81f7098551/life-13-01557-g005.jpg

相似文献

1
A Ferroptosis-Related lncRNAs Signature Predicts Prognosis of Colon Adenocarcinoma.一种与铁死亡相关的长链非编码RNA特征可预测结肠腺癌的预后。
Life (Basel). 2023 Jul 13;13(7):1557. doi: 10.3390/life13071557.
2
The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma.干扰素γ相关长链非编码RNA特征预测结肠癌预后并提示免疫微环境浸润
Front Oncol. 2022 Jun 7;12:876660. doi: 10.3389/fonc.2022.876660. eCollection 2022.
3
Development and validation of a ferroptosis-related lncRNAs prognosis signature in colon cancer.开发和验证结肠癌中与铁死亡相关的 lncRNAs 预后特征。
Bosn J Basic Med Sci. 2021 Oct 1;21(5):569-576. doi: 10.17305/bjbms.2020.5617.
4
Establishment of a novel ferroptosis-related lncRNA pair prognostic model in colon adenocarcinoma.建立一种新型结直肠腺癌铁死亡相关 lncRNA 对预后模型。
Aging (Albany NY). 2021 Oct 5;13(19):23072-23095. doi: 10.18632/aging.203599.
5
Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma.铁死亡相关基因特征在结肠腺癌中的预后意义
World J Clin Cases. 2021 Oct 16;9(29):8671-8693. doi: 10.12998/wjcc.v9.i29.8671.
6
Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.构建新型胆碱代谢相关标志物,预测结肠腺癌的预后、免疫图谱和化疗反应。
Front Immunol. 2022 Nov 14;13:1038927. doi: 10.3389/fimmu.2022.1038927. eCollection 2022.
7
An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.一种用于预测结肠腺癌预后、免疫微环境和化疗反应的肿瘤内异质性相关特征
Front Med (Lausanne). 2022 Jul 7;9:925661. doi: 10.3389/fmed.2022.925661. eCollection 2022.
8
Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.鉴定用于预测结肠腺癌预后、免疫微环境和候选药物的糖酵解和乳酸相关基因特征。
Front Cell Dev Biol. 2022 Aug 23;10:971992. doi: 10.3389/fcell.2022.971992. eCollection 2022.
9
Ferroptosis-Related Long Noncoding RNAs as Prognostic Marker for Colon Adenocarcinoma.铁死亡相关长链非编码RNA作为结肠腺癌的预后标志物
Appl Bionics Biomech. 2022 Apr 8;2022:5220368. doi: 10.1155/2022/5220368. eCollection 2022.
10
The construction of a novel ferroptosis-related lncRNA model to predict prognosis in colorectal cancer patients.构建新型铁死亡相关 lncRNA 模型预测结直肠癌患者预后
Medicine (Baltimore). 2023 Mar 10;102(10):e33114. doi: 10.1097/MD.0000000000033114.

引用本文的文献

1
Role of non-coding RNA-regulated ferroptosis in colorectal cancer.非编码RNA调控的铁死亡在结直肠癌中的作用
Cell Death Discov. 2025 Jul 8;11(1):315. doi: 10.1038/s41420-025-02606-6.
2
Ferroptosis-related LncRNAs in diseases.疾病中与铁死亡相关的长链非编码RNA
BMC Biol. 2025 Jun 6;23(1):158. doi: 10.1186/s12915-025-02268-x.
3
Identification of a PANoptosis-related long noncoding rna risk signature for prognosis and immunology in colon adenocarcinoma.鉴定一种与全凋亡相关的长链非编码RNA风险特征用于预测结肠腺癌的预后和免疫情况

本文引用的文献

1
Modulation of miR-146b by N6-methyladenosine modification remodels tumor-associated macrophages and enhances anti-PD-1 therapy in colorectal cancer.N6-甲基腺苷修饰调控 miR-146b 重塑肿瘤相关巨噬细胞,增强结直肠癌抗 PD-1 治疗。
Cell Oncol (Dordr). 2023 Dec;46(6):1731-1746. doi: 10.1007/s13402-023-00839-0. Epub 2023 Jul 5.
2
Targeting crosstalk of STAT3 between tumor-associated M2 macrophages and Tregs in colorectal cancer.靶向结直肠癌中肿瘤相关 M2 巨噬细胞与 Treg 之间 STAT3 的串扰。
Cancer Biol Ther. 2023 Dec 31;24(1):2226418. doi: 10.1080/15384047.2023.2226418.
3
METTL3-Modulated Promotes Colorectal Cancer Stemness and Metastasis through Increasing mRNA Stability by Recruiting IGF2BP1.
BMC Cancer. 2025 Apr 10;25(1):662. doi: 10.1186/s12885-025-14021-2.
4
Long non-coding RNAs in humans: Classification, genomic organization and function.人类中的长链非编码RNA:分类、基因组组织与功能
Noncoding RNA Res. 2025 Jan 13;11:313-327. doi: 10.1016/j.ncrna.2025.01.004. eCollection 2025 Apr.
5
Prognosis and chemotherapy drug sensitivity in liver hepatocellular carcinoma through a disulfidptosis-related lncRNA signature.通过一个与二硫键凋亡相关的长非编码 RNA 特征预测肝细胞肝癌的预后和化疗药物敏感性。
Sci Rep. 2024 Mar 26;14(1):7157. doi: 10.1038/s41598-024-57954-7.
METTL3 通过招募 IGF2BP1 增加 mRNA 稳定性来调节促进结直肠癌干性和转移。
Cancers (Basel). 2023 Jun 11;15(12):3148. doi: 10.3390/cancers15123148.
4
Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors.抗 HVEM mAb 治疗在体外和体内均改善抗肿瘤免疫,在表达人类 HVEM 和 BTLA 分子的新型转基因小鼠模型中,该模型受到表达 HVEM 的肿瘤的挑战。
J Immunother Cancer. 2023 May;11(5). doi: 10.1136/jitc-2022-006348.
5
SCUBE2 mediates bone metastasis of luminal breast cancer by modulating immune-suppressive osteoblastic niches.SCUBE2 通过调节免疫抑制性成骨细胞龛促进腔型乳腺癌的骨转移。
Cell Res. 2023 Jun;33(6):464-478. doi: 10.1038/s41422-023-00810-6. Epub 2023 May 4.
6
YTHDF1 Promotes Bladder Cancer Cell Proliferation via the METTL3/YTHDF1-RPN2-PI3K/AKT/mTOR Axis.YTHDF1 通过 METTL3/YTHDF1-RPN2-PI3K/AKT/mTOR 轴促进膀胱癌细胞增殖。
Int J Mol Sci. 2023 Apr 7;24(8):6905. doi: 10.3390/ijms24086905.
7
Effects of Helicobacter pylori on the expression of the FTO gene and its biological role in gastric cancer.幽门螺杆菌对FTO基因表达的影响及其在胃癌中的生物学作用。
Oncol Lett. 2023 Feb 28;25(4):143. doi: 10.3892/ol.2023.13729. eCollection 2023 Apr.
8
Interfering with ITGB1-DT expression delays cancer progression and promotes cell sensitivity of NSCLC to cisplatin by inhibiting the MAPK/ERK pathway.干扰ITGB1-DT表达可通过抑制MAPK/ERK途径延缓癌症进展并提高非小细胞肺癌对顺铂的细胞敏感性。
Am J Cancer Res. 2022 Jul 15;12(7):2966-2988. eCollection 2022.
9
LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancer.用光增强的双特异性抗体武装 T 细胞治疗免疫治疗耐药的结肠癌。
Oncogene. 2022 Apr;41(14):2054-2068. doi: 10.1038/s41388-022-02209-w. Epub 2022 Feb 17.
10
Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy.结直肠癌中的肿瘤浸润淋巴细胞:免疫治疗的基本指征和应用。
Front Immunol. 2022 Jan 14;12:808964. doi: 10.3389/fimmu.2021.808964. eCollection 2021.